Psykey, Inc. (CEOS)
USD 0.03
(4.52%)
USD 0.03
(4.52%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.01 Million USD | -23.55% |
| 2022 | 1.32 Million USD | 159.29% |
| 2021 | 509.84 Thousand USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 3933.20 USD | 0.0% |
| 2018 | 3933.20 USD | 0.0% |
| 2016 | 3.9 Million USD | 11.3% |
| 2015 | 3.5 Million USD | 74.49% |
| 2014 | 2 Million USD | 0.0% |
| 2007 | 1.15 Million USD | 453.23% |
| 2006 | 209.14 Thousand USD | 4082.94% |
| 2005 | 5000.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 1.01 Million USD | -23.55% |
| 2023 Q3 | 1.61 Million USD | 8.46% |
| 2023 Q4 | 1.01 Million USD | -37.5% |
| 2023 Q1 | 1.39 Million USD | 5.33% |
| 2023 Q2 | 1.49 Million USD | 7.07% |
| 2022 Q2 | 569.33 Thousand USD | 5.71% |
| 2022 Q4 | 1.32 Million USD | 8.16% |
| 2022 FY | 1.32 Million USD | 159.29% |
| 2022 Q1 | 538.6 Thousand USD | 5.64% |
| 2022 Q3 | 1.22 Million USD | 114.68% |
| 2021 Q1 | 53.37 Thousand USD | 0.0% |
| 2021 FY | 509.84 Thousand USD | 0.0% |
| 2021 Q4 | 509.84 Thousand USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2020 FY | - USD | -100.0% |
| 2019 FY | 3933.20 USD | 0.0% |
| 2018 FY | 3933.20 USD | 0.0% |
| 2016 FY | 3.9 Million USD | 11.3% |
| 2015 FY | 3.5 Million USD | 74.49% |
| 2014 FY | 2 Million USD | 0.0% |
| 2008 Q2 | 145.94 Thousand USD | -87.12% |
| 2008 Q3 | 130.97 Thousand USD | -10.26% |
| 2008 Q1 | 1.13 Million USD | -2.05% |
| 2007 FY | 1.15 Million USD | 453.23% |
| 2007 Q4 | 1.15 Million USD | 404.77% |
| 2007 Q1 | 287.34 Thousand USD | 37.39% |
| 2007 Q3 | 229.22 Thousand USD | -11.29% |
| 2007 Q2 | 258.4 Thousand USD | -10.07% |
| 2006 Q4 | 209.14 Thousand USD | 43.43% |
| 2006 Q2 | 160.87 Thousand USD | -12.78% |
| 2006 FY | 209.14 Thousand USD | 4082.94% |
| 2006 Q1 | 184.45 Thousand USD | 0.0% |
| 2006 Q3 | 145.81 Thousand USD | -9.36% |
| 2005 FY | 5000.00 USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -102.12% |
| Ansell Limited | 855.59 Million USD | 99.882% |
| Ansell Limited | 857.2 Million USD | 99.882% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 95.491% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -4727.323% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.923% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.923% |
| Encision Inc. | 1.33 Million USD | 24.198% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 56.227% |
| Innovative MedTech Inc. | 1.87 Million USD | 46.194% |
| LifePoint, Inc. | 446.74 Thousand USD | -126.217% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 81.265% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | 53.833% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -316.495% |
| SmileDirectClub, Inc. | 871.79 Million USD | 99.884% |
| Sector 10, Inc. | 164 Thousand USD | -516.22% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.85% |
| SheerVision, Inc. | 75 Thousand USD | -1247.467% |
| United Health Products, Inc. | 755.98 Thousand USD | -33.679% |
| Vasamed, Inc. | 23.45 Thousand USD | -4209.595% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | 63.482% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -27.843% |